Erik Atkisson - Sep 30, 2021 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
GC & Chief Compliance Officer
Signature
/s/ Sriram Ryali, Attorney-in-Fact
Stock symbol
EIGR
Transactions as of
Sep 30, 2021
Transactions value $
$0
Form type
4
Date filed
10/1/2021, 04:35 PM
Previous filing
Oct 1, 2021
Next filing
Mar 11, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +180K $0.00 180K Sep 30, 2021 Common Stock 180K $6.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as follows: 25% of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of September 20, 2021, with the remaining shares to vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such date.